The Early Treatment Phase in Parkinson’s Disease: Not a Honeymoon for All, Not a Honeymoon at All?

Author:

Alonso-Canovas Araceli12,Voeten Jos3,Gifford Larry4,Thomas Omotola5,Lees Andrew J.6,Bloem Bastiaan R.7

Affiliation:

1. Movement Disorders Unit, Neurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain

2. Faculty of Medicine, Universidad de Alcalá, Alcalá de Henares, Spain

3. Rijkswaterstaat, Eindhoven, The Netherlands

4. Parkinson’s Africa, London, UK

5. PD Avengers, Vancouver, BC, Canada

6. The National Hospital for Neurology and Neurosurgery, London, UK

7. Department of Neurology, Radboud University Medical Center, Donders Institute for Brain and Cognition, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands

Abstract

The discovery of levodopa in the late 60 s of twentieth century was a ‘golden moment’ for people with Parkinson’s disease (PD). Unfortunately, clinical experience showed that some symptoms escaped from symptomatic control, and long-term complications developed. Back then, neurologists coined the term “honeymoon period” for the early phase of uncomplicated response to levodopa, and it continues to be used in scientific literature. However, medical terms are no longer restricted to professionals, and few people with PD relate to the notion of a “honeymoon”. We examine the reasons why this term, once helpful, but inaccurate and inappropriate, should be abandoned.

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference30 articles.

1. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr;Lees;Mov Disord,2015

2. Modification of Parkinsonism: Chronic treatment with L-dopa;Cotzias;N Engl J Med,1969

3. Long-term side-effects of levodopa;Barbeau;Lancet,1971

4. Freezing of gait and its levodopa paradox;Nonnekes;JAMA Neurol,2020

5. Sacks O (1973) Awakenings. Duckworth & Co. 408 p. ISBN 0-375-70405-1.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3